Unité de Fabrication des Médicaments S.A (BVMT: UMED)

BVMT: UMED Revenue

Unité de Fabrication des Médicaments S.A had revenue of 74.75M TND in the half year ending December 31, 2023, with 70.49% growth. This brings the company's revenue in the last twelve months to 141.07M, up 22.48% year-over-year. In the year 2023, Unité de Fabrication des Médicaments S.A had annual revenue of 136.00M with 41.14% growth.

• Revenue (ttm): 141.07M
• Revenue Growth: +22.48%
• P/S Ratio: n/a
• Revenue / Employee: 246.63K
• Employees: 572
• Market Cap: 225.60M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	136.00M	39.64M	41.14%
Dec 31, 2022	96.36M	11.85M	14.02%
Dec 31, 2021	84.51M	-6.53M	-7.18%
Dec 31, 2020	91.04M	-16.16M	-15.07%
Dec 31, 2019	107.21M	20.12M	23.10%